Total serum bilirubinemia and intensity of sulfur mustard exposure in Iranian chemical victims 20 years after exposure

Toxin Reviews

Volumn 28, Issue 1, 2009, Pages 44-47

  Nadoushan, Mohammad Reza Jalali ^a   Ghazanfari, Tooba ^a   Yaraee, Roya ^a   Mahdavi, Mohammad Reza Vaez ^a   Soroush, Mohammad Reza ^b   Moaiedmohseni, Sakine ^a   Ghasemi, Hassan ^a   Shams, Jalaleddin ^a   Fallahi, Faramarz ^a   Ardestani, Sussan K ^c   Malekpour, Basir ^a   Sha Ali, Akbar ^a   Hassan, Zuhair Mohammad ^d   Faghihzadeh, Soghrat ^d  

^a SHAHED UNIVERSITY   (Iran)

^b JANBAZAN MEDICAL AND ENGINEERING RESEARCH CENTER JMERC   (Iran)

^c UNIVERSITY OF TEHRAN   (Iran)

^d TARBIAT MODARES UNIVERSITY   (Iran)

Author keywords

Bilirubin; Hemolysis; Liver function tests; Sardasht Iran Cohort Study; Sulfur mustard

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BILIRUBIN GLUCURONIDE; HEMOGLOBIN; MUSTARD GAS;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; ERYTHROCYTE COUNT; EXPOSURE; HEMATOCRIT; HUMAN; HYPERBILIRUBINEMIA; IRAN; MAJOR CLINICAL STUDY; MALE; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME;

EID: 70350575136     PISSN: 15569543     EISSN: 15569551     Source Type: Journal    
DOI: 10.1080/15569540802689865     Document Type: Article

References (13)

1. Cowan FM, Broomfield CA, Smith WJ. (2002): Suppression of sulfur mustard-increased IL-8 in human keratinocyte cell cultures by serine protease inhibitors: implications for toxicity and medical countermeasures. Cell Biol Toxicol 18:175-180.
2. Balali-Mood M, Navaeian A. (1986): Clinical and paraclinical findings in 233 patients with sulfur mustard poisoning. In: ed. Heyndrickx B. Proceedings of the Second World Congress on New Compounds in Biological and Chemical Warfare. Ghent, Belgium: 7 Rijksuniversiteit, pp. 1464-1473.
3. Ghazanfari T, Faghihzadeh S, Aragizadeh H, Soroush MR, Yaraee R, Hassan ZM et al. (2009): Sardasht-Iran cohort study of chemical warfare victims: Design and methods, Arch Irnian Med 12(1): 5-14.
4. Hassan SM, Ebtekar M, Ghanei M, Taghikhani M, Daloii MRN, Ghazanfari T (2006): Immunological consequences of sulfur mustard contamination. Iran J Allergy Asthma Immunol 5:101-108.
5. Kaplan M, Hammerman C. (2005): Understanding severe hyper-bilirubinemia and preventing kernicterus: adjuncts in the interpretation of neonatal serum bilirubin. Clin Chim Acta 356:9-21.
6. Kehe K, Szinicz L. (2005): Medical aspects of sulphur mustard poisoning. Toxicology 214:198-209.
7. Keyhani A, Eslami MB, Razavimanesh H. (2007): The short-term effect of mustard gas on the serum immunoglobulin levels. Iran J Allergy Asthma Immunol 6:15-19.
8. Mahmoudi M, Hefazi M, Rastin M, Balali-Mood M. (2005): Long-term hematological and immunological complications of sulfur mustard poisoning in Iranian veterans. Int Immunopharmacol 5:1479-1485.
9. Moreno BA, Gonzalez ML, Mendoza-Jimenez J, Garcia-Buey L, Moreno OR. (2007): Utility of analytical parameters in the diagnosis of liver disease. An Med Interna 24:38-46.
10. Papirmeister B, Feister AJ, Robinson SI, Ford RD. (1991): Current theories of sulfur mustard cytotoxicity medical defense against mustard gas: mechanism and pharmacological implication. Boca Raton, FL: CRC Press, 174-186.
11. Smith KJ, Skelton H. (2003): Chemical warfare agents: their past and continuing threat and evolving therapies. Part I of II. Skin Med 2:215-221.
12. Stevenson DK, Dennery PA, Hintz SR. (2001): Understanding newborn jaundice. J Perinatol 21:S21-S24.
13. United Nations Security Council. (1988): Report of the mission dispatched by the secretary general to investigate allegations of the use of chemical weapons in the conflict between the Islamic Republic of Iran and Iraq. April 25, 1988. S/19823 and S/19823/Addendum 1. New York: United Nations.